Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5929279 | 0.78 | — | — | |
| SCHEMBL15000925 | 0.78 | ALDH1A1 (0.35) | — | |
| SCHEMBL14456136 | 0.75 | HDAC8 (0.33) | — | |
| SCHEMBL15000927 | 0.73 | KDM4E (0.31) | BACE1 | |
| SCHEMBL21835118 | 0.72 | TRPA1 (0.35) | TRPA1DRD2BACE1 | |
| SCHEMBL6528281 | 0.71 | GPR84 (0.33) | TRPA1 | |
| SCHEMBL29450353 | 0.71 | GPR84 (0.33) | TRPA1 | |
| SCHEMBL28461077 | 0.70 | BACE1 (0.33) | TRPA1DRD2BACE1 | |
| SCHEMBL407792 | 0.70 | DRD2 (0.33) | TRPA1DRD2BACE1 | |
| SCHEMBL9461527 | 0.69 | PPARA (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12383624-B2 | Cargo delivery system and composition comprising the same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-08-12 | — | — | US | claimed |
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | claimed |
| CN-118307571-A | 2, 6-Modified boron fluoride fluorescent molecule and preparation method and application thereof | 无锡学院 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024050513-A1 | PHENOTHIAZINES FOR TREATING MITOCHONDRIAL DISEASE | ACUREX BIOSCIENCES CORPORATION (US) | 2024-03-07 | — | — | WO | disclosed |
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20220275348-A1 | ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS | ROCHE DIABETES CARE, INC. | 2022-09-01 | — | — | US | disclosed |
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-07-05 | — | — | US | disclosed |
| EP-3760607-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | Takasago International Corporation (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-12-24 | — | — | US | disclosed |
| CN-110343100-B | Phenothiazine co-sensitizer and preparation method and application thereof | 江苏理工学院 | 2020-10-30 | — | — | CN | disclosed |
| WO-2012040599-A1 | RADICALLY POLYMERIZABLE PHENOTHIAZINE MACROMONOMER FOR USE IN THE COATING OF MEDICAL DEVICES | BAYER HEALTHCARE LLC (US) | 2012-03-29 | — | — | WO | disclosed |
| CN-102369615-A | Organic electroluminescent element and material for organic electroluminescent element | IDEMITSU KOSAN CO | 2012-03-07 | — | — | CN | disclosed |
| CN-102334210-A | Organic electroluminescent element | IDEMITSU KOSAN CO | 2012-01-25 | — | — | CN | disclosed |
| US-20110253944-A1 | NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME | LUMINANO CO., LTD. (KR) | 2011-10-20 | — | — | US | disclosed |
| CN-101925851-A | Liquid-crystal alignment material and liquid-crystal display element | NISSAN CHEMICAL IND LTD | 2010-12-22 | — | — | CN | disclosed |
| CN-101925850-A | Liquid-crystal alignment material, liquid-crystal alignment film, and liquid-crystal display element | NISSAN CHEMICAL IND LTD | 2010-12-22 | — | — | CN | disclosed |
| CN-1202800-A | Herbicidal composition | NOVARTIS AG (CH) | 1998-12-23 | — | — | CN | disclosed |
| CN-1144526-A | Thiazolidines and oxazolidines substituted by pyridine ring and their use a hypoglycemic agents | NISSAN CHEMICAL IND LTD (JP) | 1997-03-05 | — | — | CN | disclosed |
| EP-0155623-A2 | Use of lipoxygenase inhibitors for the preparations of cytoprotective pharmaceutical compostions and process for the preparation of a cytoprotective pharmaceutical composition | MERCK & CO. INC. (US) | 1985-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | NEK4, TENT4A, TCF4 | TRPA1 2148/4885DRD2 2975/4885BACE1 1379/4885 |
| US-12383624-B2 | Cargo delivery system and composition comprising the same | ATG7, SQSTM1, BECN1 | TRPA1 4401/4885DRD2 4330/4885BACE1 2525/4885 |
| US-20110253944-A1 | NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME | TYR, FTO, PIEZO1 | TRPA1 40/4885DRD2 1830/4885BACE1 1419/4885 |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | NEK4, TENT4A, TCF4 | TRPA1 2148/4885DRD2 2975/4885BACE1 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.